Keywords

Animal Experimentation; Arrhythmias, Cardiac; Cardiac Catheterization; Cardiac Electrophysiology; Cardiac Imaging Techniques; Cardiac Pacing, Artificial; Cardiac Resynchronization Therapy; Cardiovascular Diseases; Coronary Artery Disease; Myocardial Ischemia

Research group(s)

• Experimental and clinical cardiology
  Head: Mariann Pavone-Gyöngyösi
  Members:
  Jakob Prömer
  Martin Riesenhuber
  Claudia Müller
  Mariann Pavone-Gyöngyösi
  Katrin Zlabinger

Research interests

Martin Riesenhuber is a medical doctor focused on clinical cardiology and cardiovascular research with broad experience in cardiac device therapy, electrophysiology and large animal models, including diagnostic and interventional coronary angiography, cardiac imaging, device and drug testing and translational studies for cardiac remodeling in pigs. He is part of the consortium of CResPace EU-project, developing a new generation of CRT devices, adapting beat-to-beat to the individual needs of patients.

During the diploma program medicine at the Medical University of Vienna (completed in 2017) he received two merit-based scholarships, gained experience in preclinical intensive care medicine and analyzed up to 1,300 24h-ECGs. He did 8 months of clinical training in Switzerland.

Working within the research group of Univ. Prof. Dr. Pavone-Gyöngyösi since 2015, he is a PhD candidate since 2017.

Techniques, methods & infrastructure

• Coronary angiography in pigs (creation of 190 reperfused myocardial infarcts and 165 diagnostic angiographies in pigs from 09/2017 to 07/2018)
• Cardiovascular Imaging including cardiac MRI
• Cardiac Drug Testing
• Cardiac Device Testing
• Broad experience in Pressure-Volume loops of the left ventricle

Selected publications

1. Klasinc R and Riesenhuber M (equal contribution), Bacher A, Willinger B, 2018. Invasive Fungal Infection Caused by Exophiala dermatitidis in a Patient After Lung Transplantation: Case Report and Literature Review. Mycopathologia. Available at: http://dx.doi.org/10.1007/s11046-018-0275-4.
2. Weisshaar S, Litschauer B, Bucher S, Riesenhuber M, Kapiotis S, Kyrle PA, Wolzt M, 2016. The effect of a dual or a triple antithrombotic therapy with apixaban on thrombus formation in vivo and in an ex vivo perfusion chamber model. Medicine, 95(27), p.e4145. Available at: http://dx.doi.org/10.1097/MD.0000000000004145.